ALR Technologies SG Ltd (ALRTF)

[GS1]

email reply from Sidney


Sidney Chan <[e-mail]>


9:40 PM (1 hour ago)

to me



We are preparing an 8k and should be filed in the next day or two.

The insiders own over 97.5% of the shares of the Company on a fully diluted basis.

We have always been marketing the ALRT Diabetes Management Platform actively.

There are 60 million insulin dependent diabetes patients in the world.



The number is growing.



The Insulin Dose Adjustment as outlined in the news release will make it easy for prescribers to titrate insulin dose for new insulin patients. This may remove one of the hurdles faced by prescribers to start patients on insulin.



For patients who are on insulin, many are not prescribed the optimal amount (which mean full amount).



If I am the CEO of an insulin pharmaceutical company, I would certainly like every patient to have an optimal dose. I would also like all patients that should use insulin to start insulin.



The management of ALR Tech knows the importance of our App to our profits, hopefully management of insulin pharmaceutical companies will realise the importance of the ALRT App for their bottom line ASAP as well. As to how many prescribers will use our App for how many patients, your projection is as good as mine.



You have the maximum number of patients that can be prescribed the App.



Best



Sidney Chan

ALR Technologies Inc.